Will failure of Lunar Lander ‘Peregrine Mission One’ affect NASA’s ‘Commercialisation’ efforts?   

The lunar lander, ‘Peregrine Mission One,’ built by ‘Astrobotic Technology’ under NASA’s ‘Commercial Lunar Payload Services’ (CLPS) initiative was launched into space on 8 January 2024. The spacecraft has since suffered propellant leak. Hence, Peregrine 1 can no longer soft land on the Moon. 

The lunar lander, ‘Peregrine Mission One,’ built by the private provider ‘Astrobotic Technology’ under NASA’s ‘Commercial Lunar Payload Services’ (CLPS) initiative was launched into space on 8 January 2024 using Vulcan Centaur vehicle developed by another contractor, United Launch Alliance.  

However, the spacecraft has since suffered propellant leak.  

Hence, Peregrine 1 can no longer soft land on the Moon.  

Astrobotic, the company that built the spacecraft has posted a message that “At this time the goal is to get Peregrine as close to lunar distance as we can before it loses the ability to maintain its Sun-pointing position and subsequently loses power.” 

NASA’s ‘Commercial Lunar Payload Services’ (CLPS) initiative:  

NASA started Commercial Lunar Payload Services (CLPS) initiative to promote innovation and growth of private space industry and to reduce cost and to accelerate lunar exploration towards Artemis mission. Under this programme, NASA contracts transportation services to American companies through competitive bidding.  

Eight moon missions have been contracted to private providers to date. ‘Peregrine Mission One’ or CLPS-1 was the first in the series. CLPS-2 is planned in February 2024. The eighth planned missions is scheduled in 2026.  

NASA’s ‘Commercialisation’ efforts have taken concrete shape with the launch of Peregrine Mission One 

*** 

References:  

  1. NASA. Peregrine Mission 1 (TO2-AB). Available at https://nssdc.gsfc.nasa.gov/nmc/spacecraft/display.action?id=PEREGRN-1 
  2. Astrobotic Technology. Update #6 For Peregrine Mission One. Available at https://www.astrobotic.com/update-6-for-peregrine-mission-one/  

*** 

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Sleep Traits and Cancer: New Evidences of Breast Cancer Risk

Synchronizing sleep-wake pattern to night-day cycle is critical for...

Treating Cancer Through Restoring Function of Tumour Suppressor Using Vegetable Extract

Study in mice and human cells describes reactivation of...

Oceanic Internal Waves Influence Deep-Sea Biodiversity

Hidden, oceanic internal waves have been found to play...

Use of Face Masks Could Reduce Spread of COVID-19 Virus

WHO doesn't recommend face masks generally to the healthy...

Climate Change Mitigation: Planting Trees in Artic Worsens Global Warming

Forest restoration and tree plantation is a well-established strategy...

Merops orientalis: Asian green bee-eater

The bird is native to Asia and Africa and...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.